Korea

FutureMain Bolsters Global Industrial AI Competitiveness with NPU-Based Time-Series AI Project

SEOUL, South Korea, Jan. 27, 2026 /PRNewswire/ -- FutureMain Co., Ltd. , a specialized industrial AI company focused on equipment diagnostics and predictive maintenance, announced that it is playing a pivotal role in a next-generation intelligent semiconductor R&D proj...

2026-01-27 22:00 994

Daesang's K-Food Brand O'food Launches Kimchi Ramyun at Costco and Loblaws in Canada

- Two Kimchi Ramyun Varieties Now Available Across Canada - Not just Kimchi flavor, Real Kimchi inside SEOUL, South Korea, Jan. 26, 2026 /PRNewswire/ -- Daesang's leading Korean food brand O'food has launched two Kimchi Ramyun products at Costco and Loblaws inCanada.

2026-01-26 21:00 2007

SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding

* CEPI to provide up to USD 30 million to support development of MSD's Zaire ebolavirus vaccine * Collaboration addresses manufacturing complexity and cold-chain challenges to improve yield and thermostability * Partnership aims to expand affordable and sustainable vaccine access in low- an...

2026-01-22 21:00 4236

Uncle Gurye Launches Premium Dried Herb Bibimbap and Korean Savory Pancake Kits Featuring Authentic Korean Ingredients

SEOUL, South Korea, Jan. 21, 2026 /PRNewswire/ -- Uncle Gurye, a premium food specialist based inSouth Korea, has announced the expansion of its Home Meal Replacement (HMR) lineup with the global launch of two new products: the Dried Herb Kit for Bibimbap and the Korean Savory Pancake Kit. Both p...

2026-01-21 21:00 3375

Hyundai Mobis Embeds 5G Wireless Telematics Technology for Autonomous and SDV Vehicles

- Hyundai Mobis has developed a telematics solution (MTCU) capable of 5G wireless communication, securing leadership in the global connectivity market - The current 4G-based telematics market is evolving with 5G technology, enabling high-precision map services and remote control - 5G solutions a...

2026-01-21 21:00 3514

FutureMain Advances AI-Based On-Device Diagnostics for High-Failure-Rate Equipment Through Government-Led R&D Program, Validating Global Industrial Applicability

SEOUL, South Korea, Jan. 21, 2026 /PRNewswire/ -- FutureMain , a South Korea–based industrial AI and asset transformation (AX) company specializing in predictive maintenance, announced that it is actively conducting phased field validation research on AI-powered self-...

2026-01-21 21:00 4740

Samsung Biologics reports fourth quarter and fiscal year 2025 financial results

* Recorded Q4'25 revenue of KRW 1,286 billion and FY'25 revenue of KRW 4,557 billion * Maintained momentum through consistent operational performance and robust client demand * Strengthened foundation for long-term growth through expanded manufacturing readiness and operational scale INC...

2026-01-21 15:20 3274

HD Hyundai Chairman Chung Kisun Discusses Future of AI and Energy at Davos Forum

* Chairman Chung attends 2026 World Economic Forum Annual Meeting for fourth consecutive year * Discusses AI-driven transformation and innovation in energy transition at key sessions * Met with Palantir co-founder and CEO Alex Karp to discuss expansion of strategic partnership SEOUL, South ...

2026-01-21 08:01 3041

Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology

DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. Under the terms of the agreement, Tesaro will acquire world-wide rights to use ALT-B4, Alteog...

2026-01-20 15:55 3219

6Letters Launches "MOJO KING," an Apple Watch-Based iOS App for Non-Invasive Testosterone Monitoring

SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- Digital healthcare startup  6Letters today announced the official launch of MOJO KING, an iOS application that enables non-invasive monitoring of testosterone-related physiological patterns using Apple Watch data.

2026-01-20 10:19 4147

RSUPPORT Validates Top-Tier Security with ISO/IEC 27001 and 27017 Certifications

Asia's No.1 Remote Solutions Provider Once Again Recognized for Outstanding Security Excellence SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- RSUPPORT Co., Ltd., a leading provider of remote solutions, announced today that its Global R&D Center has achieved two internationally recognized inf...

2026-01-19 21:30 3178

INCHEON-IFEZ Booth Wraps Up a Successful CES 2026, Recording $560M in Export Consultations and 17 Innovation Awards

Over 15,000 visitors to the INCHEON–IFEZ Booth; IFEZ supported a record 50 innovation companies participating in CES 2026. Participating companies secure a foundation for global expansion, including 20 MoU signings. INCHEON, South Korea, Jan. 16, 2026 /PRNewswire/ -- The Incheon Free Economic Zo...

2026-01-16 16:06 2912

Hugel accelerates global value creation with U.S.-led growth strategy

- President and Global CEO Carrie Strom outlines mid-term growth strategy including global vision, U.S. channel strategy, and portfolio expansion - Hugel targets KRW900 billion in total net sales and 30% of sales from U.S. by 2028 SAN FRANCISCO, Jan. 15, 2026 /PRNewswire/ -- Hugel, Inc., a leadin...

2026-01-16 08:00 3096

ESTsoft and Samsung Electronics Unveil 'AI Promoter' at CES 2026, Delivering an Innovative Exhibition Experience

* 'AI Promoter' engages global tech leaders at Samsung Electronics' The First Look event at CES 2026 * Highly praised for enabling natural interactions through advanced on-device AI and object recognition technologies * CEO Sangwon Chung: "We will continue to deliver increasingly sophisticat...

2026-01-15 22:00 4422

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

YONGIN, South Korea, Jan. 15, 2026 /PRNewswire/ -- GCCL, a leading South Korea -based provider of clinical trial sample analysis, and OPIS, a global full-service contract research organization (CRO), have signed a Memorandum of Understanding (MOU) on the sidelines of the 44th Annual J.P. Morgan He...

2026-01-15 15:31 2185

Yuyu Pharma Establishes UCLA Office to Accelerate U.S. Pet Industry Expansion

SEOUL, South Korea, Jan. 14, 2026 /PRNewswire/ -- Yuyu Bio and Mervyn's Petcare, pet-focused subsidiaries of Yuyu Pharma, have opened a new office on theUCLA campus, strengthening the company's presence in the United States pet and animal health market. The two companies are now based at Magni...

2026-01-14 22:00 3681

Celltrion presents innovative drug pipeline and U.S. manufacturing and R&D expansion strategy at the 44th Annual J.P. Morgan Healthcare Conference

* Celltrion outlines a blueprint for innovative drug development built on its antibody expertise * The company highlights its business strategy to scale U.S. manufacturing and R&D capabilities, strengthening its global supply chain, production and operations INCHEON, South Korea, Jan. 13, 202...

2026-01-14 09:18 2551

WIRobotics Concludes CES 2026, Advancing into Execution Phase of Global Collaboration Across Humanoid and Wearable Robotics

YONGIN, South Korea, Jan. 13, 2026 /PRNewswire/ -- WIRobotics, a global robotics company co-led by Co-CEOs Younbaek Lee andYongjae Kim, announced the successful conclusion of its participation at CES 2026, marking a shift from technology demonstration to the execution phase of global collaboratio...

2026-01-14 01:00 1834

Deepson Bio Receives Presidential Award at 2025 Korea Invention Patent Exhibition

Award highlights promise of ultrasound-based innovation in addressing unmet needs in dementia treatment SEOUL, South Korea, Jan. 12, 2026 /PRNewswire/ -- Deepson Bio Co., Ltd., a medical technology company focused on ultrasound-based approaches to dementia treatment, was honored with the Preside...

2026-01-12 22:00 664

Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery

TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol...

2026-01-12 16:00 941
12345 ... 133